Abhinav Deol - Researcher Profile | RDL Research Database

Publications

2 shown

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke , Armin Ghobadi , Caron A. Jacobson +28 more

2018 The Lancet Oncology 2108 citations

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja , Deepu Madduri , Saad Z. Usmani +33 more

CARTITUDE-1 aimed to assess the safety and clinical activity of ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T-cell therapy with two B-cell maturation anti...

2021 The Lancet 1466 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 3,574
Institution: The Barbara Ann Karmanos Cancer Institute

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0003-0947-8871

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.